A Study to Determine the Effect of Food on the Pharmacokinetics of Oral AZD8931 Tablets
Study identifier:D0102C00011
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A Randomised, Open-label, Phase I Study to Determine the Effect of Food on the Pharmacokinetics of Oral AZD8931 Tablets in Healthy Subjects
Medical condition
Healthy
Phase
Phase 1
Healthy volunteers
Yes
Study drug
AZD8931
Sex
Male
Actual Enrollment
24
Study type
Interventional
Age
18 Years - 55 Years
Date
Study Start Date: 01 Mar 2009
Primary Completion Date: -
Study Completion Date: 01 Jul 2009
Study design
Allocation: N/A
Endpoint Classification: Pharmacokinetics Study
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Basic Science
Verification:
Verified 01 Jan 2014 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| Experimental: 1 160mg oral dose of AZD8931 | Drug: AZD8931 160mg oral single dose (4 x 40mg tablets) |
Contacts
Investigators
Principal Investigator
Emeline Ramos
AstraZeneca, Clinical Pharamcology Unit, Alderley Park
